Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 26, 2024; 12(24): 5628-5635
Published online Aug 26, 2024. doi: 10.12998/wjcc.v12.i24.5628
Treatment of nasopharyngeal carcinoma and prevention of non-alcoholic Wernicke’s disease: A case report and review of literature
Yu-Yang Ma, Xiao-Chan He, Yu Gao, Tian-Tian Ma, Gong Cheng, Chang-Wu Yue
Yu-Yang Ma, Yu Gao, Chang-Wu Yue, Yan’an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan’an University, Yan’an 716000, Shaanxi Province, China
Yu-Yang Ma, Tian-Tian Ma, Gong Cheng, Department of Cardiology, Second Division, Shaanxi Provincial People’s Hospital, Xi’an 710000, Shaanxi Province, China
Xiao-Chan He, Xi’an Honghui Hospital, Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China
Co-first authors: Yu-Yang Ma and Xiao-Chan He.
Co-corresponding authors: Gong Cheng and Chang-Wu Yue.
Author contributions: Ma YY and He XC contributed equally to this work and should be considered co-first authors. Ma YY acquired and analysed the work, drafted the manuscript, and collected and analysed the images; He XC, Gao Y, and Ma TT edited the manuscript; Cheng G and Yue CW wrote, proofread, and edited the manuscript, they contributed equally to this work and should be considered co-corresponding author; all authors have met the authorship requirements for the submitted version and have agreed to its submission.
Informed consent statement: The patient consented to treatment and provided written consent for publication of this study. we have de-identified the information regarding the patients that is included in the article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chang-Wu Yue, PhD, Professor, Yan’an Key Laboratory of Microbial Drug Innovation and Transformation, School of Basic Medicine, Yan’an University, No. 580 Shengdi Road, Baota District, Yan’an 716000, Shaanxi Province, China.changwuyue@yau.edu.cn
Received: May 9, 2024
Revised: June 20, 2024
Accepted: July 2, 2024
Published online: August 26, 2024
Processing time: 62 Days and 20.5 Hours
Core Tip

Core Tip: Following concurrent chemoradiotherapy in a patient with nasopharyngeal carcinoma, we diagnosed a case of Wernicke’s encephalopathy. This article further outlines the current diagnostic techniques for Wernicke encephalopathy and the latest advancements in retrospective studies related to Wernicke encephalopathy. This finding provides a new perspective for research on the diagnosis and preventive measures of Wernicke encephalopathy associated with head and neck malignancies.